Transplantation and the Use of Raltegravir in HIV-Infected Patients

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2015 by Duke University
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Duke University
ClinicalTrials.gov Identifier:
NCT01793467
First received: February 13, 2013
Last updated: August 3, 2015
Last verified: August 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: October 2015 (Final data collection date for primary outcome measure)